OTC · USD
HRGN
Sign in to followHarvard Apparatus Regenerative Technology, Inc.
Export transactions ↓Last 12 months
Inside the activity.
3 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 1 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 2 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 28, 2023 Filed Sep 5, 2023 11:43 UTC |
He JunliDirector · CEO
|
PurchaseCommon Stock | 3,400 | $4.69 | $15,946.00 |
DisclosureSEC source: 0001493152-23-031566 · ownership.xml · nonDerivative · entry 1 He Junli · CIK 0001728598 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 246,400 F1 · date: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from August 28, 2023 to September 1, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| August 21, 2023 Filed Aug 23, 2023 20:14 UTC |
Shmerling James E.Director
|
PurchaseCommon Stock | 6,864 | $4.35 | $29,858.40 |
DisclosureSEC source: 0001493152-23-030013 · ownership.xml · nonDerivative · entry 1 Shmerling James E. · CIK 0001505051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,756 Read SEC document |
| August 18, 2023 Filed Aug 28, 2023 14:13 UTC |
He JunliDirector · CEO
|
PurchaseCommon Stock | 8,000 | $4.32 | $34,560.00 |
DisclosureSEC source: 0001493152-23-030317 · ownership.xml · nonDerivative · entry 1 He Junli · CIK 0001728598 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 243,000 F1 · date: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions from August 18, 2023 to August 25, 2023. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
GREEN DAVIDDirector
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025853 · ownership.xml · derivative · entry 2 GREEN DAVID · CIK 0001008643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
GREEN DAVIDDirector
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025853 · ownership.xml · derivative · entry 1 GREEN DAVID · CIK 0001008643 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
Packard Ronald JDirector
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025854 · ownership.xml · derivative · entry 2 Packard Ronald J · CIK 0001420478 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
Packard Ronald JDirector
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025854 · ownership.xml · derivative · entry 1 Packard Ronald J · CIK 0001420478 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
Shmerling James E.Director
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025855 · ownership.xml · derivative · entry 2 Shmerling James E. · CIK 0001505051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 16:00 UTC |
Shmerling James E.Director
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025855 · ownership.xml · derivative · entry 1 Shmerling James E. · CIK 0001505051 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Chen JingDirector
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025858 · ownership.xml · derivative · entry 2 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Chen JingDirector
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025858 · ownership.xml · derivative · entry 1 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Sanchez HermanDirector
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025856 · ownership.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Sanchez HermanDirector
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025856 · ownership.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Li TingDirector
|
GrantStock Option (right to buy) · Derivative | 5,819 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025857 · ownership.xml · derivative · entry 2 Li Ting · CIK 0001759813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,819 Underlying: Common Stock, par value $0.01 per share · 5,819 shares Expires 2033-07-26 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, September 30, 2023, December 31, 2023 and March 31, 2024. Read SEC document |
| July 26, 2023 Filed Jul 28, 2023 20:00 UTC |
Li TingDirector
|
GrantStock Option (right to buy) · Derivative | 7,269 | $0.00 Strike: $4.10 | $0.00 |
DisclosureSEC source: 0001493152-23-025857 · ownership.xml · derivative · entry 1 Li Ting · CIK 0001759813 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,269 Underlying: Common Stock, par value $0.01 per share · 7,269 shares Expires 2033-07-26 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 26, 2023, January 26, 2024, April 26, 2024 and July 26, 2024. Read SEC document |
| April 12, 2023 Filed May 2, 2023 11:52 UTC |
Packard Ronald JDirector
|
GrantStock Option (right to buy) · Derivative | 4,839 | $0.00 Strike: $6.05 | $0.00 |
DisclosureSEC source: 0001493152-23-015150 · ownership.xml · derivative · entry 1 Packard Ronald J · CIK 0001420478 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,839 Underlying: Common Stock, par value $0.01 per share · 4,839 shares Expires 2033-04-12 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on July 12, 2023, October 12, 2023, January 12, 2024 and April 12, 2024. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 15:24 UTC |
He JunliDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 488,256 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001493152-23-011956 · ownership.xml · derivative · entry 2 He Junli · CIK 0001728598 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 488,256 Underlying: Common Stock, par value $0.01 per share · 488,256 shares Expires 2033-04-10 F2 · derivative.exercise_date: Subject to continued employment or service through the applicable vesting dates, up to 488,256 shall vest in two increments, each for 244,128 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer. Read SEC document |
| April 10, 2023 Filed Apr 12, 2023 15:24 UTC |
He JunliDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 732,384 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001493152-23-011956 · ownership.xml · derivative · entry 1 He Junli · CIK 0001728598 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 732,384 Underlying: Common Stock, par value $0.01 per share · 732,384 shares Expires 2033-04-10 F1 · derivative.exercise_date: Subject to continued employment or service through the applicable vesting dates, the non-qualified stock option will vest monthly in thirty-six equal monthly installments on each monthly anniversary of April 10, 2023. Read SEC document |
| April 10, 2023 Filed Jul 10, 2023 19:47 UTC Amendment |
He JunliDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 267,616 | $0.00 Strike: $6.08 | $0.00 |
DisclosureSEC source: 0001493152-23-024107 · ownership.xml · derivative · entry 1 He Junli · CIK 0001728598 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 267,616 Underlying: Common Stock, par value $0.01 per share · 267,616 shares Expires 2033-04-10 F1 · derivative.exercise_date: On April 12, 2023, the Reporting Person filed a Form 4 (the "Original Form 4"), which noted a stock option (right to buy) of 488,256 shares (also known as milestone options) of Biostage, Inc. On July 10, 2023, the Issuer and Reporting Person amended and corrected such option amount to 267,616 shares. This amendment is being filed to amend and restate the reporting of those stock options to report the corrected amount. Subject to continued employment or service through the applicable vesting dates, up to 267,616 shall vest in two increments, each for 133,808 shares, each such vesting subject to certain performance milestones set by the Board of Directors of the Issuer. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:00 UTC |
DST Capital LLC10% owner
|
OtherWarrants (right to buy) · Derivative | 110,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001493152-23-011747 · ownership.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 140,000 Underlying: Common Stock · 110,000 shares Expires 2026-09-01 F2 · kind: These warrants were transferred by the Reporting Person to two unaffiliated persons. Read SEC document |
| April 06, 2023 Filed Apr 10, 2023 21:00 UTC |
DST Capital LLC10% owner
|
PurchaseCommon Stock | 62,500 | $6.00 | $375,000.00 |
DisclosureSEC source: 0001493152-23-011747 · ownership.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,725,825 F1 · price: On March 31, 2023, the Issuer and the Reporting Person entered into a securities purchase agreement pursuant to which on April 6, 2023 the Reporting Person acquired 62,500 shares of the Issuer's common stock, $0.01 par value (the "Shares") from the Issuer in a private placement. The aggregate subscription amount paid by the Reporting Person for the Shares was $375,000. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 20:00 UTC |
GREEN DAVIDDirector · CEO as of 2/28/2023
|
GrantStock Option (right to buy) · Derivative | 732,384 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001493152-23-006611 · ownership.xml · derivative · entry 3 GREEN DAVID · CIK 0001008643 · Director · CEO as of 2/28/2023 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 732,384 Underlying: Common Stock, par value $0.01 per share · 732,384 shares Expires 2033-02-28 F3 · derivative.exercise_date: The non-qualified stock option was scheduled to vest monthly in thirty-six equal monthly installments on each monthly anniversary of February 28, 2023, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, 488,256 shares underlying this option have been forfeited, and subject to the Reporting Person's execution of a customary release, the remaining 244,128 shares will be deemed fully vested and exercisable. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 20:00 UTC |
GREEN DAVIDDirector · CEO as of 2/28/2023
|
GrantStock Option (right to buy) · Derivative | 38,773 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001493152-23-006611 · ownership.xml · derivative · entry 2 GREEN DAVID · CIK 0001008643 · Director · CEO as of 2/28/2023 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,773 Underlying: Common Stock, par value $0.01 per share · 38,773 shares Expires 2033-02-28 F2 · derivative.exercise_date: The non-qualified stock option was scheduled to vest during the twelve months following the grant date, but in connection with the Issuer's transition to a new CEO as of March 1, 2023, this option has been forfeited. Read SEC document |
| February 28, 2023 Filed Mar 2, 2023 20:00 UTC |
GREEN DAVIDDirector · CEO as of 2/28/2023
|
GrantStock Option (right to buy) · Derivative | 39,662 | $0.00 Strike: $6.00 | $0.00 |
DisclosureSEC source: 0001493152-23-006611 · ownership.xml · derivative · entry 1 GREEN DAVID · CIK 0001008643 · Director · CEO as of 2/28/2023 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,662 Underlying: Common Stock, par value $0.01 per share · 39,662 shares Expires 2033-02-28 F1 · derivative.exercise_date: This stock option grant was fully exercisable as of date of grant. Read SEC document |
| January 25, 2023 Filed Jan 27, 2023 10:52 UTC |
GREEN DAVIDDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 47,651 | $0.00 Strike: $6.46 | $0.00 |
DisclosureSEC source: 0001415889-23-001502 · form4-01272023_030146.xml · derivative · entry 1 GREEN DAVID · CIK 0001008643 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,651 Underlying: Common Stock, par value $0.01 per share · 47,651 shares Expires 2033-01-25 F1 · derivative.exercise_date: Subject to continued employment through the applicable vesting dates, the non-qualified stock option will vest monthly in twelve equal monthly installments on each monthly anniversary of January 25, 2023. Read SEC document |
| December 12, 2022 Filed Jan 5, 2023 19:26 UTC |
He JunliDirector
|
SaleCommon Stock | 135 | $6.83 | $922.05 |
DisclosureSEC source: 0001415889-23-000497 · form4-01052023_070112.xml · nonDerivative · entry 1 He Junli · CIK 0001728598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 235,000 Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
DST Capital LLC10% owner
|
OtherWarrants (right to buy) · Derivative | 7,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2022-12-27 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 7,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 1,952 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 5,048 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
DST Capital LLC10% owner
|
SaleCommon Stock | 1,952 | $7.17 | $13,995.84 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · nonDerivative · entry 2 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,663,325 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 7,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 1,952 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 5,048 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
DST Capital LLC10% owner
|
OtherCommon Stock | 7,000 | $2.00 | $14,000.00 |
DisclosureSEC source: 0001415889-22-012350 · form4-12092022_101229.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,665,277 Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
Yu HongPRESIDENT
|
OtherWarrants (right to buy) · Derivative | 300,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012348 · form4-12092022_101241.xml · derivative · entry 4 Yu Hong · CIK 0001743047 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Indirect · The spouse of the reporting person Disclosed balance after: 0 Underlying: Common Stock · 300,000 shares Expires 2022-12-27 F1 · kind: On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
Yu HongPRESIDENT
|
SaleCommon Stock | 83,676 | $7.17 | $599,956.92 |
DisclosureSEC source: 0001415889-22-012348 · form4-12092022_101241.xml · nonDerivative · entry 2 Yu Hong · CIK 0001743047 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Indirect · The spouse of the reporting person Disclosed balance after: 222,459 F1 · kind: On December 7, 2022, the Spouse of the Reporting Person exercised a warrant to purchase 300,000 shares of common stock for $2 per share. The Spouse of the Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 83,676 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 216,324 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:21 UTC |
Yu HongPRESIDENT
|
OtherCommon Stock | 300,000 | $2.00 | $600,000.00 |
DisclosureSEC source: 0001415889-22-012348 · form4-12092022_101241.xml · nonDerivative · entry 1 Yu Hong · CIK 0001743047 · PRESIDENT 10b5-1 filing: Not disclosed Ownership: Indirect · The spouse of the reporting person Disclosed balance after: 306,135 Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:19 UTC |
Chen JingDirector
|
OtherWarrants (right to buy) · Derivative | 174,000 | $0.00 Strike: $2.00 | $0.00 |
DisclosureSEC source: 0001415889-22-012347 · form4-12092022_101252.xml · derivative · entry 3 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 174,000 shares Expires 2022-12-27 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 174,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 48,532 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 125,468 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:19 UTC |
Chen JingDirector
|
SaleCommon Stock | 48,532 | $7.17 | $347,974.44 |
DisclosureSEC source: 0001415889-22-012347 · form4-12092022_101252.xml · nonDerivative · entry 2 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,468 F1 · kind: On December 7, 2022, the Reporting Person exercised a warrant to purchase 174,000 shares of common stock for $2 per share. The Reporting Person paid the exercise price on a cashless basis, resulting in Biostage's withholding of 48,532 shares to pay the exercise price based on the daily VWAP of $7.1706, and issuing the remaining 125,468 shares of common stock. Read SEC document |
| December 07, 2022 Filed Dec 9, 2022 22:19 UTC |
Chen JingDirector
|
OtherCommon Stock | 174,000 | $2.00 | $348,000.00 |
DisclosureSEC source: 0001415889-22-012347 · form4-12092022_101252.xml · nonDerivative · entry 1 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 210,000 Read SEC document |
| August 08, 2022 Filed Aug 9, 2022 18:06 UTC |
DAMASIO JOSEPH LUIS JRChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 116,156 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001104659-22-088076 · tm2222955-3_4seq1.xml · derivative · entry 1 DAMASIO JOSEPH LUIS JR · CIK 0001450080 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 116,156 Underlying: Common Stock, par value $0.01 per share · 116,156 shares Expires 2032-08-08 F1 · derivative.exercise_date: Subject to continued employment through the applicable vesting dates, these shares vest in four equal annual increments on each anniversary of the grant date. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:48 UTC |
He JunliDirector
|
GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076927 · tm2220305-4_4seq1.xml · derivative · entry 2 He Junli · CIK 0001728598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5.016 shares Expires 2032-06-29 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:48 UTC |
He JunliDirector
|
GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076927 · tm2220305-4_4seq1.xml · derivative · entry 1 He Junli · CIK 0001728598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 17:59 UTC |
Shmerling James E.Director
|
GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076937 · tm2220305-2_4seq1.xml · derivative · entry 2 Shmerling James E. · CIK 0001505051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5,016 shares Expires 2032-06-29 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 17:59 UTC |
Shmerling James E.Director
|
GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076937 · tm2220305-2_4seq1.xml · derivative · entry 1 Shmerling James E. · CIK 0001505051 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:54 UTC |
Sanchez HermanDirector
|
GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076933 · tm2220305-1_4seq1.xml · derivative · entry 2 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5,016 shares Expires 2032-06-09 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:54 UTC |
Sanchez HermanDirector
|
GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076933 · tm2220305-1_4seq1.xml · derivative · entry 1 Sanchez Herman · CIK 0001843559 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:50 UTC |
Chen JingDirector
|
GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076931 · tm2220305-3_4seq1.xml · derivative · entry 2 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5.016 shares Expires 2032-06-29 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:50 UTC |
Chen JingDirector
|
GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076931 · tm2220305-3_4seq1.xml · derivative · entry 1 Chen Jing · CIK 0001727177 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:49 UTC |
Li TingDirector
|
GrantStock Option (right to buy) · Derivative | 5,016 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076929 · tm2220305-5_4seq1.xml · derivative · entry 2 Li Ting · CIK 0001759813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,016 Underlying: Common Stock, par value $0.01 per share · 5,016 shares Expires 2032-06-29 F2 · derivative.exercise_date: This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, June 30, 2022, September 30, 2022 and December 31, 2022. Read SEC document |
| June 29, 2022 Filed Jul 1, 2022 21:49 UTC |
Li TingDirector
|
GrantStock Option (right to buy) · Derivative | 6,241 | $0.00 Strike: $4.65 | $0.00 |
DisclosureSEC source: 0001104659-22-076929 · tm2220305-5_4seq1.xml · derivative · entry 1 Li Ting · CIK 0001759813 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,241 Underlying: Common Stock, par value $0.01 per share · 6,241 shares Expires 2032-06-29 F1 · derivative.exercise_date: This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on September 29, 2022, December 29, 2022, March 29, 2023 and June 29, 2023. Read SEC document |
| May 18, 2022 Filed May 20, 2022 23:02 UTC |
He JunliDirector
|
GrantStock Option (right to buy) · Derivative | 6,813 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001104659-22-063531 · tm2216257-2_4seq1.xml · derivative · entry 1 He Junli · CIK 0001728598 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,813 Underlying: Common Stock, par value $0.01 per share · 6,813 shares Expires 2032-05-18 F1 · derivative.exercise_date: This stock option grant was fully exercisable as of date of grant. Read SEC document |
| May 18, 2022 Filed May 20, 2022 23:02 UTC |
Yu HongPresident
|
GrantStock Option (right to buy) · Derivative | 22,089 | $0.00 Strike: $4.71 | $0.00 |
DisclosureSEC source: 0001104659-22-063530 · tm2216257-1_4seq1.xml · derivative · entry 1 Yu Hong · CIK 0001743047 · President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,089 Underlying: Common Stock, par value $0.01 per share · 22,089 shares Expires 2032-05-18 F1 · derivative.exercise_date: This stock option grant was fully exercisable as of date of grant. Read SEC document |
| May 12, 2022 Filed May 20, 2022 00:47 UTC |
DST Capital LLC10% owner
|
PurchaseWarrants (right to buy) · Derivative | 4,139 | Not disclosed Strike: $8.88 | Not disclosed |
DisclosureSEC source: 0001104659-22-063025 · tm2216158-1_4seq1.xml · derivative · entry 3 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,139 Underlying: Common Stock · 4,139 shares Expires 2027-05-12 F1 · kind: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. F1 · price: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. Read SEC document |
| May 12, 2022 Filed May 20, 2022 00:47 UTC |
DST Capital LLC10% owner
|
PurchaseCommon Stock | 8,277 | $5.92 | $48,999.84 |
DisclosureSEC source: 0001104659-22-063025 · tm2216158-1_4seq1.xml · nonDerivative · entry 1 DST Capital LLC · CIK 0001727656 · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,658,277 F1 · price: On May 12, 2022, the Issuer and the Reporting Person entered into a securities purchase agreement (the "Purchase Agreement") pursuant to which the Reporting Person acquired from the Issuer in a private placement: (i) 8,277 shares of the Issuer's common stock, $0.01 par value (collectively, the "Shares"); and (ii) warrants to purchase up to 4,139 shares of common stock with an exercise price of $8.88 per share (the "Warrants"). The aggregate subscription amount paid by the Reporting Person for the Shares and Warrants acquired by it pursuant to the Purchase Agreement was $49,000. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.